E-DRUG: Nevirapine and breastfeeding study: Lack of reduced risk for infants
-------------------------------------------------------------------------------------
Six-Week Course Of Antiretroviral Nevirapine Did Not Clearly Reduce Risk Of HIV Among Breastfed Infants, Study Finds